Genomic instability (GIN) can trigger cellular responses including checkpoint activation, senescence, and inflammation. Though extensively studied in cell culture and cancer paradigms, little is known about the impact of GIN during embryonic development, a period of rapid cellular proliferation. We report that GIN-causing mutations in the MCM2-7 DNA replicative helicase render female mouse embryos to be dramatically more susceptible than males to embryonic lethality. This bias was not attributable to X-inactivation defects, differential replication licensing, or X vs Y chromosome size, but rather "maleness," since XX embryos could be rescued by transgene-mediated sex reversal or testosterone (T) administration. The ability of exogenous or endogenous T to protect embryos was related to its anti-inflammatory properties. The NSAID ibuprofen rescued female embryos containing mutations not only in MCM genes but also Fancm, which have elevated GIN from compromised replication fork repair. Additionally, deficiency for the anti-inflammatory IL10 receptor was synthetically lethal with the GIN-causing Mcm4 Chaos3 helicase mutant. Our experiments indicate that embryonic and maternal GIN arising from DNA replication-associated DNA damage induces embryonic inflammation likely via the cGAS-STING response, preferentially killing female embryos while male embryos are protected by high levels of intrinsic T. 3 Compromised DNA replication or replication-associated repair can lead to GIN. Such replicative stress (RS) can be induced environmentally or by intrinsic genetic defects such as oncogene expression or mutation of DNA replication and repair genes 1,2 .
halt in cell cycle progression that is particularly impactful for rapidly proliferating cells 3 .
Embryogenesis constitutes one of the most dramatic examples of rapid and choreographed cell proliferation, thus GIN can potentially have profound effects upon a fetus. Cells experiencing chronic RS, GIN, or DNA damage can exhibit a "senescenceassociated secretory phenotype" (SASP), typified by secretion of several proteins including inflammatory cytokines that can inhibit growth of neighboring cells in a culture system 4 . SASP is related to the cGAS/STING pathway that induces an inflammatory response triggered by the presence of cytoplasmic DNA 5 . Though senescence and the SASP have normal functions in certain compartments during embryonic development 6, 7 , little is known about potential consequences of fetal or maternal GIN-induced inflammation during gestation.
DNA replication requires the minichromosome maintenance (MCM) complex, composed of 6 proteins (MCM2-7) that constitute the catalytic core of the replicative helicase. Experimental reduction of MCMs causes RS by reducing the number of dormant ("backup") origins that are important for completing DNA replication in the face of spontaneous or induced replication fork stalling or collapse [8] [9] [10] . We previously described a hypomorphic allele of the mouse gene Mcm4 (Mcm4 Chaos3 ; abbreviated Mcm4 C3 hereafter) that was identified in a screen for mutants with elevated micronuclei (membrane-encapsulated cytoplasmic chromosome fragments) 11 . Highly cancer-prone, this allele causes GIN by destabilizing the MCM2-7 helicase and triggering TRP53mediated reduction (~40%) of MCM2-7 in mouse embryonic fibroblasts (MEFs) [12] [13] [14] .
Although Table S5) 12 .
To determine the stage(s) of development that Mcm4 C3/C3 Mcm2 Gt/+ animals were dying and if this coincided with female-biased lethality, we conducted timed matings of Previous studies showed that in MEFs derived from Mcm mutant mice, decreased MCM levels correlated with a reduction in dormant replication origins 15, 16 Mcm6 Gt/+ female embryos preferentially, increasing female viability from 0% to 27% in the former, and from 3% to 42% in the latter (Fig. 1a , Tables S1,S2). Mcm3 heterozygosity also increased viability of Mcm4 C3/C3 Mcm2 Gt/+ newborns from 30% to 72%, but both sexes were rescued approximately proportionately ( Fig. 1a ; Table S3 ). 5 We conjecture that the degree of preferential female rescue is related to overall degree of lethality in compound mutants (93%, 82% and 70% lethality for Mcm4 C3 Fig. 1 ), indicating that X-inactivation occurs normally.
Next, to distinguish between hypotheses 2 and 3 (whether the larger size of the X vs secondary sexual characteristics might underlie the sex bias), a single experiment was performed. Sex determination occurs from E9.5-12.5, when the bipotential gonad differentiates down the male or female pathway 19 . During this interval, expression of the Y-linked sex determining gene Sry is critical for initiating testis development by triggering the differentiation of precursor cells into pre-Sertoli cells 20 . We induced sex reversal of XX Mcm4 C3/C3 Mcm2 Gt/+ embryos with an autosomal Sry transgene (Sry129 Tg4Ei) 21 . Strikingly, presence of the Sry transgene increased the proportion of XX Mcm4 C3/C3 Mcm2 Gt/+ mice from 20% to 48% (Fig 2a; Table S6 ). These results indicate that maleness, and not the presence of two X chromosomes per se, protects embryos from MCM deficiency. These data are also consistent with the finding that preferential female embryo death only occurred after sex determination. 6 Since sex reversal rescued lethality of XX embryos, we hypothesized that testosterone (T) might be responsible. It is produced at high levels by Leydig cells in embryonic testes, beginning at ~E12.5 and persisting throughout gestation 22 . To test this, we treated pregnant females bearing embryos of the Mcm4 C3/C3 Mcm2 Gt/+ genotype with daily injections of testosterone propionate beginning at E7.5. Fetuses were collected and genotyped at E19.5 (T-treated dams cannibalized newborns). The viability of XX animals from T-treated mothers (XX females were masculinized by T) increased dramatically compared to the untreated embryos ( Fig. 2a ; Table S7 ), rising from 22% to 54% for this genotype.
Regarding the mechanism by which T protects untreated male and T-treated female embryos from GIN, we first considered the possibility that it does so by increasing replication licensing. It was reported that the androgen receptor, to which T and its more potent metabolite dihydrotestosterone binds, stimulates proliferation of prostate cancer cells by acting as a replication factor 23, 24 . However, there were no sex-specific differences in MCM2 or MCM4 protein levels in E13.5 fetuses or placentae of various genotypes (Extended Data Mcm2 Gt/+ mice, we treated pregnant females beginning at 7.5 days of gestation with 7 ibuprofen in their drinking water, then genotyped their newborns. Strikingly, ibuprofen completely abolished the sex bias, decreasing the male (XY) to female (XX) sex ratio from 2:1 to 1:1 without altering secondary sex characteristics ( Fig. 2a , Extended Data Table 1a ). The NSAID treatment did not affect MCM protein levels in embryos or placentae (Extended Data Fig. 2b, c) .
The findings that two distinct anti-inflammatory molecules (one steroidal, the other not) rescued XX embryos is consistent with the interpretation that GIN and resulting elevated micronuclei caused by the DNA replication defects cause inflammation that leads to preferential female embryonic lethality. Nevertheless, because ibuprofen and the androgen receptor (which is strongly induced by T exposure; Fig. 2c ) can alter expression of genes unrelated to inflammation [30] [31] [32] , we used an orthogonal approach to further test the idea that inflammation underlies embryonic lethality in the MCM mutants.
We hypothesized that genetically increasing inflammation by ablating the receptor (Il10rb) for the anti-inflammatory cytokine IL10 would exacerbate the phenotype of
In the course of breeding such mice, we found that the genotype of Mcm4 C3/C3 Il10rb -/caused highly penetrant lethality to embryos of both sexes (Extended Data Table 1c ). IL10 mediates a feedback loop under conditions of inflammation to induce degradation of Ptgs2/Cox2 transcripts 33 , and also counters the inflammation response triggered by the STING pathway 34 . To confirm that the synthetic lethality of Il10r -/with Mcm4 C3/C3 was due to inflammation, we treated pregnant females with NSAID during gestation. This rescued both males and females of the Mcm4 C3/C3 Il10rb -/genotype, increasing viability from 8.9% to 94% (Extended Data   Table 1c ). These results indicate that the level of GIN in certain Mcm4 C3/C3 tissues, even in the absence of addition MCM deletions, can cause inflammatory responses that can be lethal unless attenuated by endogenous or exogenous anti-inflammatories.
Successful pregnancy requires suppression of inflammation at the maternal:fetal interface. Because homozygosity for Chaos3 alone causes a ~20 fold increase in micronucleated erythrocytes without decreasing viability in the C3H background 11 , and 8 IL10 is thought to play a role in suppressing maternal inflammation at the fetal:maternal interface 35 , we considered the possibility that maternal genotype might influence viability of MCM compound mutant embryos. To test this, we mated females Table 1b ).
These data led us to hypothesize that maternal homozygosity for Chaos3 imposes additional stress on the placentae of genetically susceptible female embryos, possibly via the cGAS/STING-driven inflammation. To test this, we examined DNA damage levels in placentae of E13.5 embryos produced in control (WT x WT) and reciprocal
and Mcm4 C3/C3 X WT crosses. Regardless of fetal genotype, placentae from embryos in which the dam was Mcm4 C3/C3 had more cells that stained positively for the double strand break (DSB) marker γH2AX than those in which the dam was of any other genotype ( Fig. 4a ). NSAID treatment did not reduce the level of γH2AX staining, consistent with the rescue effect being related to inflammation, not DNA damage or GIN per se (Fig. 4a ).
Given the maternally-induced DNA damage in the placenta and the evidence that inflammation is responsible for the preferential death of females in our mouse model, we hypothesized that GIN-induced placental inflammation might underlie the lethality.
We tested this in three ways. First, if this model is true, then it implicates the placenta as potentially being the culpable defective tissue responsible for embryonic death. To explore this, we examined MCM levels in the placentae vs. embryo proper of various genotype of embryos. We observed significant reductions in placental, but not embryonic MCM2 and MCM4 (especially MCM4) in Chaos3 mutant genotypes, regardless of maternal genotype or whether the dams were NSAID-treated (Extended Data Fig. 2a-c) . Thus, placental cells may be particularly sensitive to DNA replication 9 defects that trigger downregulation of MCM production and consequent increases in GIN 13, 36 . Second, because the cGAS-STING pathway has emerged as the primary means by which GIN and cytoplasmic DNA (e.g. micronuclei) induces an innate immune response, we stained WT and unique to these models. We therefore attempted to parse the key proximal defects that trigger the sex bias by exposing WT embryos to either exogenous RS alone or DSBs alone. Pregnant females treated with hydroxyurea, an agent that causes RS by depleting nucleotide pools, delivered pups without sex skewing (M:F 1.08, 127 live births, p-value=0.5396 using one-tailed Fisher Exact Test). Similarly, chronic exposure to ionizing radiation (50 mGy administered 3X/week beginning at E1.5) of pregnant females also failed to produce a sex bias (M:F 1.00, 32 live births). We then conjectured 10 that cytoplasmic DNA arising specifically from chronic DNA replication defects might be responsible for inflammation-driven female-biased embryonic lethality. It was reported that mice with mutations in Fancm (Fanconi Anemia M), encoding a protein important for stabilization and repair of DNA replication forks, cause elevated erythrocyte micronuclei 38 and under-representation of homozygous female offspring in a mixed strain background 39 Fig. 2a , Extended Data Table 1d ). These results indicate that defective DNA replication and/or replication-associated DNA repair results in an inflammatory response (likely driven by elevated micronuclei) that preferentially kills female embryos.
In humans, the male:female birth rate is ~1.05 40 . Studies of spontaneous abortuses from women with recurrent miscarriages have revealed a highly preferential loss of female fetuses unrelated to karyotypic abnormalities, ~10 fold in one study 41 and 1.7 fold in another 42 . The biological basis for the preferential sensitivity of post-sexdetermination stage female embryos in humans is unknown. However, our results raise the possibility that ~midgestation NSAID administration during pregnancies involving conditions of maternal inflammation may have protective effects for the fetus. Graphed are percent viability at birth of males and females for each of the indicated genotypes versus C3/C3 littermates. For Fancm, the viability is versus WT littermates. The numbers on or over the bars = # males or females of the indicated genotype, and the N values below equal the total number of newborns with that genotype. Some of the data for all genotypes except that involving M5 were reported in 12 , but broken out by sex here and with added data that are enumerated in Extended Data Table 1 and Tables S1-S5. "* " represents a Chi-Squared test probability of p<0.01 that females are underrepresented vs males from that genotype. "<>" represents a significant Fisher Exact Test (p<0.05) between indicated groups in terms of the ability of 
Fig. 2. Evidence that the anti-inflammatory activity of testosterone protects male embryos from genomic instability-induced lethality. (A) Viability of genetically female (XX)
Mcm4 C3/C3 Mcm2 Gt/+ or Fancm -/embryos is rescued by Sry transgene-induced sex reversal (Sry Tg), and treatment of pregnant dams with either testosterone ("Testos") or ibuprofen ("NSAID").
Values above each bar are total mice, and those inside bars are XX. Nontransgenics and transgenics in the Sry Tg experiment were from the same cross. The untreated mice in the testosterone and NSAID experiments are from Table S3 and also plotted in Fig. 1a female and no drug treatment. For Il10rb, the strain was obtained from Jax Mice (stock#005027) and backcrossed into the C3Heb/FeJ(Jax stock#000658) background for six generations (N6) before crossing into the Mcm4 C3 strain for 2 additional generations (N2). Mcm4 C3/C3 Il10rb +/males were mated to Mcm4 C3/C3 Il10rb +/females and provided with ibuprofen as described above. Newborns were genotyped with primers for Il10rb (Table S9) .
Genotyping. Genomic DNA was isolated from animal tissue using the hot-shot lysis procedure 3 . Genotyping PCR was carried out using Taq and gene-specific primer pairs (Table S9) . For Chaos3 genotyping, the PCR products were digested with MboII to identify mutant alleles as Chaos3 but not wild-type alleles are digestible with this enzyme. For Mcm5, ES cells were verified using primers containing regions outside of the gene trap insertion to verify. To determine the sex of early embryos, primers for Sry (Sex-determining region Y) were used to identify males, females are Sry negative.
Genotyping for Mcm2-7 genetraps has been previously described 4 . Mcm5 was confirmed by PCR as described in genotyping section (Table S9) . Following germline transmission, the mutation was backcrossed into C3H for ≥ 4 generations before crossing to C3H-Mcm4 Chaos3 mice.
Generation of
Generation of FancM mice. Fancm em1/Jcs was generated using CRISPR/Cas9mediated genome editing. In summary, an optimal guide sequence targeting the first exon of Fancm was designed using the mit.crispr.edu website. Oligos to generate the sgRNA DNA template were ordered from Integrated DNA Technologies (IDT) and the sgRNA was in vitro transcribed as described previously 5 (CRISPR-FancF: GAAATTAATACGACTCACTATAGGCCAGCTGGTAGTCGCGCACGGTTTTAGAGCTA GAAATAGC, CRISPR-FancR: CAAAATCTCGATCTTTATCGTTCAATTTTATTCCGATCAGGCAATAGT TGAACTTTTTCACCGTGGCTCAGCCACGAAAA). Embryo microinjection into C57BL/6J zygotes was performed as described previously 6 using 50ng/uL of sgRNA and 50ng/uL of Cas9 mRNA (TriLink Biotechnologies). The resulting 7bp deletion was identified via Sanger sequencing and subsequent genotyping was performed with primers sets specific to the mutant and wild-type alleles. (Table S9 ). 22 Flow cytometry to monitor X-inactivation. A transgenic mouse containing an Xlinked EGFP was obtained and crossed to Mcm4 Chaos3 mice. FACS analysis of embryos was carried out as described 7 Embryonic semi-lethality and female sex bias caused by the FancM em1Jcs/em1Jcs genotype (is rescued by ibuprofen treatment of pregnant females.) Cross: ♀ Fancm em1Jcs/+ X ♂ Fancm em1Jcs/+ . Red numbers are plotted in Fig. 2A . 
